Clindamycin for Management of Staphylococcal Deep Pyoderma-A Clinical Study of 12 Dogs Chirayath Deepa1,*, Rathish R.L. Department of Clinical Veterinary Medicine, College of Veterinary and Animal Sciences, Kerala Veterinary and Animal Sciences University (KVASU), Mannuthy, Thrissur-680657, Kerala 1Assistant Professor, Department of Clinical Veterinary Medicine, College of Veterinary and Animal Sciences, Kerala Veterinary and Animal Sciences University (KVASU), Mannuthy, Thrissur-680657, Kerala *Corresponding author. E-mail: deepachirayath@kvasu.ac.in
Online published on 2 April, 2016. Abstract A study was conducted to evaluate the efficacy of Clindamycin once daily orally in the management of canine deep pyoderma caused by Staphylococcus in-vitro and in-vivo. Twelve dogs presented with symptoms of deep pyoderma and positive cultures of Staphylococcus sp. were selected for the study. The sensitivity of staphylococcal cultures to Clindamycin was done in-vitro and dogs were treated with Clinidamycin @ 11mg/kg b.wt. for 21 days and response to therapy was assessed. All 12 isolates were sensitive to Clindamycin in-vitro. Eleven dogs treated with Clindamycin showed excellent response. Complete resolution of infection was observed on 21st day in seven cases. Recovery was observed in 28 days in another four cases. In one case, even after two months of treatment with Clindamycin, complete cure was not obtained. Recurrence was reported in one dog after three months. Top Keywords Canine, clindamycin, staphyloccus, pyoderma. Top |